Navigation Links
FDLI, PEN co-sponsor major conference on nanotechnology
Date:12/10/2007

Nanotechnology was incorporated into more than $50 billion in manufactured goods last year, according to Lux Research. By 2014, the market will grow to $2.6 trillion. By 2011, over $15 billion in nano-enabled drugs and therapeutics will be soldup from more than $3 billion in 2006. And industry experts project that nanotechnology will be incorporated into $20 billion worth of consumer food products by 2010.

Yet, despite this rapid commercialization, no nano-specific regulation exists anywhere in the world. Most regulatory agencies remain in an information-gathering modelacking the legal and scientific tools, information and resources they need to adequately oversee exponential nanotechnology market growth.

Now, for the first time, top officials at the agencies responsible for the regulation of nanotechnology productsincluding the Food and Drug Administration, Environmental Protection Agency, Occupational Safety and Health Administration and Department of Agriculturewill meet at a Food and Drug Law Institute conference to discuss their plans for managing and monitoring these products.

At FDLIs 1st Annual Conference on Nanotechnology Law, Regulation and Policy, February 28-29, 2008, at the LEnfant Plaza Hotel, in Washington, DC, food and drug industry representatives also will find out whats happening internationally on nanotech regulation, how venture capitalists look at the future of nanotechnology and what the leading corporations, scientific laboratories and academic centers are focusing on in this dynamic field.

This groundbreaking conference, co-sponsored by the Woodrow Wilson International Center for Scholars Project on Emerging Nanotechnologies, in partnership with Arizona State University and the Burdock Group, will address the crucial issues surrounding nanotechnology law, regulation and policy, including:

  • What first and second generation nanotechnology products already are on the market, and what is to come?
  • Is Congress ready to act on nanotechnology if federal regulators do not?
  • Do Europe and Asia approach nanotechnology safety and oversight differently than the United States?
  • How do consumers see nanoproducts?
  • When it comes to nanotechnology, should size make a regulatory difference?

Michael Taylor, Research Professor of Health Policy, School of Public Health and Health Services, The George Washington University, and author of the most comprehensive report published on nanotechnology regulation at FDA, Regulating the Products of Nanotechnology, Does FDA Have the Tools It Needs?, will present the keynote address. Also, Sen. Ron Wyden (D-Ore.), co-chair of the Congressional Nanotechnology Caucus, and invited luncheon speaker, will discuss future congressional actions in this area.

Top-level FDA officials, including Associate Commissioner for Science Norris Alderson; Deputy Commissioner for Policy Randall W. Lutter; Deputy Associate General Counsel Jeffrey Senger; and Director of Food Additive Safety Laura Tarantino, will appear on a special panel on FDA regulation of nanotechnology.

Other featured speakers and moderators include:

Jay M. Ansell, Personal Care Products Council;
Susan D. Brienza, Of Counsel, Patton Boggs LLP;
George Burdock, President, Burdock Group;
Robert W. Carpick; University of Pennsylvania Director, The Nanotechnology Institute;
Ricardo Carvajal; Counsel, Reed Smith LLP;
Jim Czaban, Partner, WilmerHale;
Lee Farrow, Senior Vice President, ACE Medical Risk;
Piotr Grodzinski, Director, NCI Alliance for Nanotechnology in Cancer, NIH;
Ralph Hall, Professor, University of Minnesota Law School;
Robert A. Hoerr, President & CEO, Nanocopoeia, Inc.;
Michael Holman. Senior Analyst, Lux Research;
Karen Hunter, Program Specialist, U.S. Department of Agriculture, Cooperative State Research, Education and Extension Service;
Rachel G. Lattimore, Partner, Arent Fox LLP;
Scott Livingston, Managing Director, Axiom Capital Management/The Livingston Group;
Jane Macoubrie, President, Embry Research;
Ellen Maldenado, Attorney-at-Law;
Gary Marchant, Lincoln Professor of Emerging Technologies, Law & Ethics
Sandra Day OConnor College of Law;
Philippe Martin, Principal Administrator, Nanotechnologies Policy Development and Coordination, Consumer Protection Directorate (DG-SANCO), European Commission;
Terry L. Medley, Global Director, Corporate Regulatory Affairs, DuPont Environment and Sustainable Growth Center;
Julia A. Moore, Deputy Director, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars;
Sean Murdock, Executive Director, NanoBusiness Alliance;
Fern P. OBrian, Partner, Arnold & Porter LLP;
Leon Radomsky, Chair, Nanotechnology Industry Team, Foley & Lardner LLP;
David W. Rejeski, Director, Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars;
Stephanie Scharf, Partner, Schoeman Updike Kauffman & Scharf;
Dietram Scheufele, Professor of Life Sciences Communication, University of Wisconsin;
Loretta Schuman, Occupational Safety and Health Administration;
Laura Sciarrino, Vice President, Legal, CV Therapeutics, Inc.; and
Jim Willis, U.S. Environmental Protection Agency.


'/>"/>

Contact: Michael Levin-Epstein
mdl@fdli.org
202-222-0897
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. deCODE discovers cause of major subtype of glaucoma
2. Bleeding, not inflammation, is major cause of early lung infection death
3. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
4. Leading experts cite poor health and nutrition as major barrier to education in developing world
5. Majority of Americans want local action on global warming, says poll
6. How schizophrenia develops: Major clues discovered
7. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
8. NIH selects LIAI for major study on allergy molecular causes and possible treatments
9. Local sources major cause of US near-ground aerosol pollution
10. Tree of life for flowering plants reveals relationships among major groups
11. Humans not the major target of Shiga toxin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2016)... , Jan. 22, 2016 ... addition of the "Global Biometrics Market ... their offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> Research and Markets ( ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
(Date:1/15/2016)... SAN JUAN, Puerto Rico , Jan. 15, 2016 ... forcing companies big and small to find new ways ... data driven culture. iOS and ... their device based on biometrics, transforming it into a ... can request that users swipe their fingerprint on their ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... ... 10, 2016 , ... Curoverse announced today that the open-source, ... capabilities for managing and processing genomic and health data at petabyte scale. ... and analyzing genomic data,” said Adam Berrey chief executive officer at Curoverse. “Microsoft ...
(Date:2/10/2016)... BC (PRWEB) , ... February 09, 2016 , ... ... design services and current winner of the Highest Overall Customer Rating Award ... in all of its business units across the USA, Canada, Mexico and China. ...
(Date:2/9/2016)... ... 08, 2016 , ... Date and time: March 1, 2016, ... Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902. ... hold an open house for participants to learn about a new Master of ...
(Date:2/9/2016)... , ... February 09, 2016 , ... Tunnell Consulting, Inc. ... Based in Paris, he will focus on acquiring new accounts and work closely with ... , “Fred brings to our European clients more than 15 years of ...
Breaking Biology Technology: